Next Article in Journal
Selective Phosphodiesterase 4B Inhibitors: A Review
Previous Article in Journal
Formulation and In Vitro Evaluation of Ofloxacin Tablets using Natural Gums as Binders
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 82
Issue 2
10.3797/scipharm.1211-14corr
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]

by
Khaled HAMDEN
1,*,
Kais MNAFGUI
2,
Zahra AMRI
2,
Ahmed ALOULOU
3 and
Abdelfattah ELFEKI
2
1
Biotechnology High School of Sfax (ISBS),University of Sfax, Soukra Km 45; PO Box 261, Sfax 3038, Tunisia
2
Laboratory of Animal Ecophysiology, University of Sfax, Faculty of Sciences of Sfax, PO Box 95, Sfax 3052, Tunisia
3
Laboratory of Biochemistry and Enzymatic Engineering of Lipases, National School of Engineers of Sfax, University of Sfax, Sfax 3038, Tunisia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2014, 82(2), 449-452; https://doi.org/10.3797/scipharm.1211-14corr
Submission received: 9 March 2014 / Accepted: 13 March 2014 / Published: 13 March 2014
Versions Notes

Abstract

This is a corrigendum to the article 'Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats' [Sci Pharm. 2013; 81: 233–246]. Figure 6 is replaced.
Keywords: Corrigendum; Sci Pharm. 2013; 81: 233–246 Corrigendum; Sci Pharm. 2013; 81: 233–246

Share and Cite

MDPI and ACS Style

HAMDEN, K.; MNAFGUI, K.; AMRI, Z.; ALOULOU, A.; ELFEKI, A. Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]. Sci. Pharm. 2014, 82, 449-452. https://doi.org/10.3797/scipharm.1211-14corr

AMA Style

HAMDEN K, MNAFGUI K, AMRI Z, ALOULOU A, ELFEKI A. Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]. Scientia Pharmaceutica. 2014; 82(2):449-452. https://doi.org/10.3797/scipharm.1211-14corr

Chicago/Turabian Style

HAMDEN, Khaled, Kais MNAFGUI, Zahra AMRI, Ahmed ALOULOU, and Abdelfattah ELFEKI. 2014. "Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]" Scientia Pharmaceutica 82, no. 2: 449-452. https://doi.org/10.3797/scipharm.1211-14corr

Article Metrics

Back to TopTop